Covered recipient · General Payments record
EDNA M HARRIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2022
$819.58
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $214.69 | 11 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $81.27 | 4 |
| Acerta Pharma LLC | $54.45 | 3 |
| UCB, Inc. | $42.30 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.68 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.98 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891971627 | CMS |
| ABBVIE INC. | $25.37 | 02/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891971629 | CMS |
| ABBVIE INC. | $23.87 | 04/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891971631 | CMS |
| ABBVIE INC. | $12.05 | 05/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891971633 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.61 | 04/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915882001 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.88 | 05/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914798293 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.96 | 06/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915752155 | CMS |
| Novartis Pharmaceuticals Corporation | $16.99 | 03/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894579225 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.68 | 03/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 956009391 | CMS |
| UCB, Inc. | $22.69 | 05/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 908109865 | CMS |
| UCB, Inc. | $19.61 | 08/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 907984947 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022
- Source files
- Dataset page · Bulk file · PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.